Variant report
Variant | nsv525169 |
---|---|
Chromosome Location | chr8:117630683-117631964 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16892766 | chr8:117630683-117630684 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
2 | rs185732959 | chr8:117630694-117630695 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190536107 | chr8:117630764-117630765 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370487360 | chr8:117630765-117630766 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17743323 | chr8:117630795-117630796 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs16892769 | chr8:117630814-117630815 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111380673 | chr8:117630884-117630885 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368280131 | chr8:117630914-117630915 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370935688 | chr8:117630929-117630930 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192965783 | chr8:117630945-117630946 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541365612 | chr8:117630994-117630995 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6990788 | chr8:117631012-117631013 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs200235517 | chr8:117631013-117631014 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs58147231 | chr8:117631014-117631015 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113597398 | chr8:117631080-117631081 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534511569 | chr8:117631090-117631091 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531758729 | chr8:117631147-117631148 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543669923 | chr8:117631188-117631189 | Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549889276 | chr8:117631220-117631221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113776113 | chr8:117631228-117631229 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142364167 | chr8:117631257-117631258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145925001 | chr8:117631278-117631279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566292806 | chr8:117631298-117631299 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111549496 | chr8:117631331-117631332 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6469652 | chr8:117631335-117631336 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs567429432 | chr8:117631337-117631338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537882645 | chr8:117631341-117631342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10105966 | chr8:117631352-117631353 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs7011668 | chr8:117631382-117631383 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs116503665 | chr8:117631397-117631398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188897321 | chr8:117631400-117631401 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572571447 | chr8:117631429-117631430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542830524 | chr8:117631446-117631447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17805446 | chr8:117631479-117631480 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs149279966 | chr8:117631481-117631482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528382590 | chr8:117631505-117631506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557288643 | chr8:117631553-117631554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564886381 | chr8:117631581-117631582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532475987 | chr8:117631590-117631591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547454165 | chr8:117631627-117631628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548534354 | chr8:117631635-117631636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566353476 | chr8:117631651-117631652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7822969 | chr8:117631676-117631677 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs367806734 | chr8:117631689-117631690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548890255 | chr8:117631736-117631737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567593196 | chr8:117631737-117631738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577188339 | chr8:117631769-117631770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375786615 | chr8:117631777-117631778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549806347 | chr8:117631786-117631787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7823142 | chr8:117631788-117631789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 20932292 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:117630400-117631000 | Enhancers | Stomach Smooth Muscle | stomach |
2 | chr8:117630400-117631200 | Enhancers | Fetal Lung | lung |
3 | chr8:117630400-117631400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr8:117630400-117631400 | Enhancers | Fetal Stomach | stomach |
5 | chr8:117630600-117630800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr8:117630600-117631000 | Weak transcription | Right Atrium | heart |
7 | chr8:117630600-117631200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr8:117630800-117631000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:117630800-117631200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr8:117630800-117631200 | Enhancers | Stomach Mucosa | stomach |
11 | chr8:117630800-117631600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr8:117631000-117631200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr8:117631000-117631200 | Genic enhancers | Right Atrium | heart |
14 | chr8:117631000-117631400 | Enhancers | Fetal Brain Female | brain |
15 | chr8:117631000-117631400 | Enhancers | Fetal Kidney | kidney |
16 | chr8:117631000-117631600 | Enhancers | Fetal Brain Male | brain |
17 | chr8:117631000-117631600 | Enhancers | Left Ventricle | heart |
18 | chr8:117631200-117635400 | Weak transcription | Fetal Lung | lung |
19 | chr8:117631200-117635400 | Weak transcription | Right Atrium | heart |
20 | chr8:117631200-117641600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr8:117631400-117635400 | Weak transcription | Fetal Stomach | stomach |
22 | chr8:117631600-117635600 | Weak transcription | Left Ventricle | heart |